00800nam0-22002891i-450-99000597192040332120051031145644.0000597192FED01000597192(Aleph)000597192FED0100059719220000112g18501851km-y0itay50------baitaITy---n---001yyCorso di diritto civile dedicato ai notai..Giuseppe MeledandriNapoliDragone1850-18512 v.44 cm34621itaMeledandri,Giuseppe227199ITUNINARICAUNIMARCBK990005971920403321VIII Y 4715760FGBCFGBCCorso di diritto civile dedicato ai notai.582695UNINA01140nam--2200373---450-99000333759020331620091021093657.0978-1-4129-5035-0000333759USA01000333759(ALEPH)000333759USA0100033375920091021d2008----km-y0itay50------baengUS||||||||001yy<<The>> theory and practice of corporate communicationa competing values perspectiveAlan T. BelasenLos Angeles [etc.]Sage2008XVII, 269 p.25 cm20012001Comunicazione aziendaleBNCF658.45BELASEN,Alan T.520526ITsalbcISBD990003337590203316658.45 BEL 2216769 L.M.658.4500229204BKECOALESSANDRA9020091021USA010933ALESSANDRA9020091021USA010934ALESSANDRA9020091021USA010936Theory and practice of Corporate communication833943UNISA01350nam 2200421Ia 450 991069922280332120230902161935.0(CKB)5470000002401681(OCoLC)493452069(EXLCZ)99547000000240168120091223d1995 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierPharmacokinetics[electronic resource] guidance for repeated dose tissue distribution studies[Rockville, MD] :[U.S. Dept. of Health and Human Services, Food and Drug Administration],[1995]1 online resource (i, 3 pages)Guideline for industry ;ICH-S3B"March 1995."Includes bibliographical reference (page 3).Guideline for industry ;ICH-S3B.Pharmacokinetics PharmacokineticsTissuesDrugsTestingPharmacokinetics.Tissues.DrugsTesting.United States.Food and Drug Administration.International Conference on Harmonisation.GPOGPOBOOK9910699222803321Pharmacokinetics1022895UNINA